Treatment options in Clostridium difficile infection

Reviews and Research in Medical Microbiology

Volumn 12, Issue 1, 2001, Pages 21-28

  Wilcox, M H ^a   Dave, J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Biotherapy; Clostridium difficile; Lactobacillus GG; Metronidazole; Saccharomyces boulardii; Vancomycin

Indexed keywords

BACITRACIN; BOVINE IMMUNOGLOBULIN; FUSIDIC ACID; IMMUNOGLOBULIN; LACTOBACILLUS VACCINE; METRONIDAZOLE; SYNSORB CD; SYNSORB PK; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; DNA FINGERPRINTING; HUMAN; IMMUNOTHERAPY; LACTOBACILLUS; NONHUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT DISEASE; RIBOSOME; SACCHAROMYCES BOULARDII;

EID: 0035136715     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200101000-00003     Document Type: Article

References (76)

1. Treatment of antibiotic associated colitis with oral vancomycin: Comparison of two dosage regimens
2. Incidence and impact of Clostridium difficile infection the UK
3. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991
4. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile associated diarrhoea and colitis
5. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease
6. Clostridium difficile infection: Responses, relapses and re-infections
7. Financial burden of hospital-acquired Clostridum difficile infection
8. Treatment of antibiotic-associated pseudomembranous colitis
9. Treatment of antibiotic associated colitis with vancomycin
10. Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial
11. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism
12. Relapse versus reinfection with Clostridium difficile
13. Recurrence of symptoms in Clostridium difficile infection - Relapse or reinfection?
14. Approach to patients with multiple relapses of antibiotic associated pseudomembranous colitis
15. Clostridium difficile colitis: Causes, cures
16. Clostridium difficile associated diarrhea in the AIDS era
17. Metronidazole resistance in Clostridium difficile: A new emerging problem?
18. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and E-test
19. Antibiotic associated colitis due to Clostridium difficile: A double blind comparison of vancomycin with bacitracin
20. Fusidic acid for the treatment of antibiotic associated colitis induced by Clostridium difficile
21. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea
22. Treatment of antibiotic associated pseudomembranous colitis with cholestyramine resin
23. Binding of Clostridium difficile cytotoxin and vancomycin by anion exchange resins
24. The role of probiotic cultures in the control of gastrointestinal health. Symposium: Probiotic bacteria: Implications for human health
25. Le traitement par l'ultra-levure des troubles intestinaux secondaires a l'antibiotherapie: Etude en double aveugle et etude clinique simple
26. Essais cliniques controles en double insu de l'ultra-levure lyophilisee. Etude multicentrique par 25 medecins de 388 cas
27. Saccharomyces boulardii: Un traitement des colites pseudomembraneuses?
28. Prevention of antibiotic-association diarrhea by Saccharomyces boulardii: A prospective study
29. Saccharomyces boulardii for Clostridium difficile associated enteropathies in infants
30. Saccharomyces boulardii: A review of an innovative biotherapeutic agent
31. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
32. Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts
33. Prevention of beta-lactam-associated diarrhoea by Saccharomyces boulardii compared with placebo
34. Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients
35. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum
36. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
37. Saccharomyces boulardii is not Saccharomyces cerevisiae
38. Species identification and virulence attributes of Saccharomyces boulardii
39. Saccharomyces boulardii fungemia ina patient receiving Ultra-levure therapy
40. Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii
41. Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea
42. Treatment of Clostridium difficile diarrhoea with brewer's yeast
43. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation
44. Beneficial effects of the administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders
45. Lactobacillus acidophilus in the treatment of functional gastrointestinal disorders
46. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
47. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea
48. Biological properties of SF 68. A new approach for the treatment of diarrheal diseases
49. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain
50. Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part 1: Bacteria
51. Lactobacillus GG and acute diarrhoea in young children in the tropics
52. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea
53. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
54. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea
55. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
56. Prevention of diarrhoea by feeding infants with an acidified milk formula containing Bifidobacterium bifidum (Bb)
57. Reduction of diarrhea illness following administration of Lactobacillus plantarium 299V in a day care facility
58. Lactobacillus GG promotes recovery from acute non bloody diarrhea in Pakistan
59. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
60. Recovery of chronic Clostridium difficile colitis with the use of lactobacillus GG
61. The effect of probiotics on Clostridium difficile diarrhea
62. Pseudomembranous enterocolitis: Mechanism of restoring floral homeostasis
63. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces
64. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients
65. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial
66. Clostridium difficile diarrhea and colonisation after treatment with abdominal infection regimens containing clindamycin or metronidazole
67. Metronidazole may inhibit intestinal colonisation with Clostridium difficile
68. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by perenteral and mucosal routes of immunization in hamsters
69. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain
70. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis
71. Passive immunisation of hamsters against disease caused by Clostridium difficile by use of a bovine immunoglobulin G concentrate
72. Anti-C. difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins
73. Survival of anti-C. difficile bovine immunoglobulin concentrate in the human gastrointestinal tract